ClinVar Miner

Submissions for variant NM_002230.4(JUP):c.1099C>G (p.Arg367Gly)

gnomAD frequency: 0.00003  dbSNP: rs76416187
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000183496 SCV000235956 uncertain significance not provided 2019-04-29 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect
Labcorp Genetics (formerly Invitae), Labcorp RCV000645200 SCV000766942 uncertain significance Naxos disease; Arrhythmogenic right ventricular dysplasia 12 2024-12-18 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 367 of the JUP protein (p.Arg367Gly). This variant is present in population databases (rs76416187, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with JUP-related conditions. ClinVar contains an entry for this variant (Variation ID: 201821). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV000645200 SCV002782084 uncertain significance Naxos disease; Arrhythmogenic right ventricular dysplasia 12 2021-11-09 criteria provided, single submitter clinical testing
Ambry Genetics RCV004020220 SCV005018136 uncertain significance Cardiovascular phenotype 2023-10-18 criteria provided, single submitter clinical testing The p.R367G variant (also known as c.1099C>G), located in coding exon 6 of the JUP gene, results from a C to G substitution at nucleotide position 1099. The arginine at codon 367 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.